Evaluation of clinical and laboratory findings in adolescents diagnosed with polycystic ovary syndrome

被引:0
作者
Er, Eren [1 ]
Ata, Aysun [2 ]
机构
[1] Tepecik Training & Res Hosp, Dept Pediat Endocrinol, Izmir, Turkiye
[2] Adana City Training & Res Hosp, Dept Pediat Endocrinol, Adana, Turkiye
来源
ANNALS OF CLINICAL AND ANALYTICAL MEDICINE | 2023年 / 14卷
关键词
Adolescent; Anti-Mullerian Hormone; Inhibin A; Inhibin B; Polycystic Ovary Syndrome; ANTI-MULLERIAN HORMONE; INHIBIN-B LEVELS; LUTEINIZING-HORMONE; INSULIN; FEATURES; LEVEL;
D O I
10.4328/ACAM.21954
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: Polycystic ovary syndrome (PCOS) is a heterogeneous condition characterized by menstrual irregularities, hyperandrogenism, obesity, hirsutism, and psychological and psychosexual morbidity. This study aims to investigate the relationship between clinical, anthropometric, laboratory and ultrasonography findings in adolescents with the diagnosis of PCOS. Material and Methods: Forty-one adolescent girls who were admitted to the Pediatric Endocrinology Clinic of Adana City Training and Research Hospital between January 2020 and December 2021 and diagnosed with PCOS according to the Rotterdam criteria were included in this retrospective cross-sectional study. Demographic data, hormonal and biochemical analysis of the patients were obtained from the files. Results: The mean age of admission of the patients was 15.62 +/- 1.43 years, and the mean age at first menarche was 11.98 +/- 1.32 years. Oligomenorrhea (90.2%) was the most common admission complaint. Comparing the groups with PCOS with and without hirsutism, a significant difference was found in inhibin-B level (66 +/- 45 ng/dl vs 107 +/- 37 ng/dl; p=0.038). When comparing the groups with and without ultrasound findings compatible with PCOS, a significant difference was found in AMH level. (11.0 +/- 7.3 mcg/L vs 5.9 +/- 2.8 mcg/L; p=0.032). When overweight or obese patients with PCOS were compared with the normal weight group, the difference was significant in HOMA-IR (5.0 +/- 6.2 vs 1.5 +/- 0.65; p=0.009) and first menstrual age (11.3 +/- 1.3 years vs 12.7 +/- 0.75 years; p=0.008). Discussion: In this study, while low inhibin-B was more common in patients with PCOS with hirsutism, AMH was found to be significantly higher in the group whose ultrasound findings were compatible with PCOS. These parameters can be investigated in the diagnosis of adolescent PCOS.
引用
收藏
页码:371 / 375
页数:5
相关论文
共 24 条
[1]   Menstrual Pattern, Reproductive Hormones, and Transabdominal 3D Ultrasound in 317 Adolescent Girls [J].
Assens, Maria ;
Dyre, Liv ;
Henriksen, Louise Scheutz ;
Brocks, Vibeke ;
Sundberg, Karin ;
Jensen, Lisa Neerup ;
Pedersen, Anette Tonnes ;
Main, Katharina M. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (09) :E3257-E3266
[2]   The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis [J].
Bozdag, Gurkan ;
Mumusoglu, Sezcan ;
Zengin, Dila ;
Karabulut, Erdem ;
Yildiz, Bulent Okan .
HUMAN REPRODUCTION, 2016, 31 (12) :2841-2855
[3]   Obesity and serum luteinizing hormone level have an independent and opposite effect on the serum inhibin B level in patients with polycystic ovary syndrome [J].
Cortet-Rudelli, C ;
Pigny, P ;
Decanter, C ;
Leroy, M ;
Maunoury-Lefebvre, C ;
Thomas-Desrousseaux, P ;
Dewailly, D .
FERTILITY AND STERILITY, 2002, 77 (02) :281-287
[4]   Inhibins, activins and follistatin in reproduction [J].
de Kretser, DM ;
Hedger, MP ;
Loveland, KL ;
Phillips, DJ .
HUMAN REPRODUCTION UPDATE, 2002, 8 (06) :529-541
[5]   Assessment of Anti-Mullerian Hormone Level in Management of Adolescents with Polycystic Ovary Syndrome [J].
Dursun, Fatma ;
Guven, Ayla ;
Yildiz, Metin .
JOURNAL OF CLINICAL RESEARCH IN PEDIATRIC ENDOCRINOLOGY, 2016, 8 (01) :55-60
[6]   Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) [J].
Fauser, BCJM ;
Chang, J ;
Azziz, R ;
Legro, R ;
Dewailly, D ;
Franks, S ;
Tarlatzis, BC ;
Fauser, B ;
Balen, A ;
Bouchard, P ;
Dahlgren, E ;
Devoto, L ;
Diamanti, E ;
Dunaif, A ;
Filicori, M ;
Homburg, R ;
Ibanez, L ;
Laven, J ;
Magoffin, D ;
Nestler, J ;
Norman, RJ ;
Pasquali, R ;
Pugeat, M ;
Strauss, J ;
Tan, S ;
Taylor, A ;
Wild, R ;
Wild, S ;
Ehrmann, D ;
Lobo, R .
HUMAN REPRODUCTION, 2004, 19 (01) :41-47
[7]  
Fazil GJ, 2023, GSC Biological and Pharmaceutical Sciences, V24, P346
[8]   CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN [J].
FERRIMAN, D ;
GALLWEY, JD .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1961, 21 (11) :1440-+
[9]   Ovarian function and metabolic factors in women with oligomenorrhea treated with metformin in a randomized double blind placebo-controlled trial [J].
Fleming, R ;
Hopkinson, ZE ;
Wallace, AM ;
Greer, IA ;
Sattar, N .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) :569-574
[10]  
Gul N, 2023, Pakistan Journal of Medical & Health Sciences, V17, P512